Malireddi RKS, Kesavardhana S, Kanneganti TD
Sprinkle with cacao nibs and optional cinnamon or sea salt
What tends to matter is the whole system: gut barrier stability, SCFA production, inflammatory balance, GLP-1 signaling, and the daily habits that keep those rhythms steady
The recently launched preventPD program at the Institute for Neurodegenerative Diseases serves those at higher risk of developing Parkinsons
Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing
Nature of Adverse Events The most commonly reported fatal complications include: Acute pancreatitis : Sudden inflammation of the pancreas, often requiring hospitalization and linked to severe abdominal pain, nausea, and fever Organ failure : In some cases, GLP-1RA drugs have been suspected of contributing to multi-organ dysfunction Cardiovascular events : Though rare, some deaths have involved cardiac arrest or stroke following GLP-1RA use Complications from off-label or unsupervised use : Several cases involved individuals obtaining GLP-1RA drugs from unregulated online sources or using counterfeit pens Its important to note that these reports do not confirm causality
